10/8/24 16:44 | 10/7/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -38 | 0.5662 | 0 | -68 | -13 | 452 | D | | | | | | | | | | | | | | |
9/11/24 16:01 | 9/9/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -2 | 0.6577 | 0 | -3 | -1 | 289 | D | | | | | | | | | | | | | | |
3/11/24 17:19 | 3/11/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -14 | 0.8820 | 0 | -15 | -5 | 292 | D | | | | | | | | | | | | | | |
2/12/24 17:23 | 2/12/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -4 | 1.01 | 0 | -4 | -1 | 307 | D | | | | | | | | | | | | | | |
11/3/23 16:40 | 11/1/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -49 | 0.7300 | 0 | -68 | -18 | 311 | D | | | | | | | | | | | | | | |
9/12/23 16:04 | 9/8/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -3 | 1.25 | 0 | -3 | -2 | 148 | D | | | | | | | | | | | | | | |
7/5/23 16:05 | 6/30/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -1 | 1.89 | 0 | 0 | 0 | 151 | D | | | | | | | | | | | | | | |
6/26/23 16:15 | 6/23/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -2 | 1.93 | 0 | -1 | -1 | 151 | D | | | | | | | | | | | | | | |
6/16/23 16:24 | 6/15/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -2 | 2.23 | 0 | -1 | -1 | 152 | D | | | | | | | | | | | | | | |
3/13/23 16:52 | 3/10/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -15 | 0.8400 | 0 | -18 | -11 | 153 | D | | | | | | | | | | | | | | |
2/15/23 17:13 | 2/13/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -4 | 0.9300 | 0 | -4 | -2 | 171 | D | | | | | | | | | | | | | | |
8/19/22 13:07 | 8/17/22 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | 0 | 0.00 | 0 | -2 | -1 | 178 | D | | | | | | | | | | | | | | |
7/1/22 16:56 | 6/30/22 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | 0 | 0.00 | 0 | -2 | -1 | 180 | D | | | | | | | | | | | | | | |
6/27/22 16:09 | 6/24/22 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | 0 | 0.00 | 0 | -1 | 0 | 181 | D | | | | | | | | | | | | | | |
6/17/22 16:21 | 6/16/22 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | 0 | 0.00 | 0 | -1 | 0 | 182 | D | | | | | | | | | | | | | | |